NCT05158816View on ClinicalTrials.gov

Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19

CompletedOBSERVATIONAL
Enrollment

295

Participants

Timeline

Start Date

September 8, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
COVID-19
Interventions
PROCEDURE

ECMO

Patients undergoing extracorporeal membrane oxygenation

Trial Locations (1)

3500

Jessa Hospital, Hasselt

All Listed Sponsors
lead

Jessa Hospital

OTHER

NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19 | Biotech Hunter | Biotech Hunter